Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 30, 2015 3:12 PM ET

Company Overview of ForSight VISION5, Inc.

Company Overview

ForSight VISION5, Inc. evaluates technologies to address patient needs in key ophthalmic markets. The company was incorporated in 2010 and is based in Menlo Park, California.

191 Jefferson Drive

Menlo Park, CA 94025

United States

Founded in 2010



Key Executives for ForSight VISION5, Inc.

Chief Executive Officer, President and Director
Chief Medical Officer
Vice President of Marketing
Compensation as of Fiscal Year 2014.

ForSight VISION5, Inc. Key Developments

ForSight VISION5 Appoints Lisa Garrett as Vice President of Finance and Administration

ForSight VISION5 announced that Lisa Garrett has joined the company as Vice President of Finance and Administration from Medtronic. Earlier this year, Medtronic acquired Corventis, Inc., for which Ms. Garrett served as Chief Financial Officer and Vice President, Human Resources. Ms. Garrett brings over 20 years of diversified finance and human resources experience to ForSight VISION5.

ForSight VISION5 Appoints Charles Semba as Chief Medical Officer

ForSight VISION5 announced that Charles Semba, MD has joined the company as Chief Medical Officer from Shire Pharmaceuticals where he served as Vice President, Clinical Medicine (Ophthalmology). Dr. Semba has over 12 years of global drug development experience with both novel small molecules and genetically-engineered proteins in ophthalmology, neurodegenerative disease, and cardiovascular medicine. Previously, he was Chief Medical Officer at SARcode Bioscience.

ForSight VISION5 Names John F. Maroney as President, CEO and Director

ForSight VISION5 announced that John F. Maroney will join the company as President, CEO and Director of the company. Since 2003, Mr. Maroney has served as a Managing Member of Delphi Ventures. Mr. Maroney will continue to serve as a Venture Partner for Delphi Ventures. Prior to joining Delphi, Mr. Maroney was President, CEO and Chairman of EndoTex Interventional Systems, Inc. Mr. Maroney also currently serves on the Advisory Boards for the College of Engineering and the Department of BioMedical Engineering at UC Davis.

Similar Private Companies By Industry

Company Name Region
Samyang Research Corp United States
Iowa Federation Of Families For Childrens Mental Health United States
All Points, Inc. United States
John Snyder Architects United States
Caledonia Group Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ForSight VISION5, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at